• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct31
Plus Therapeutics released FY2025 9 Months Earnings on October 30, 2025 (EST) with actual revenue of USD 3.846 M and EPS of USD -29.5631
03:00
Plus Therapeutics released FY2025 Q3 earnings on October 30 (EST), actual revenue USD 1.397 M (forecast USD 1.5 M), actual EPS USD -0.0411 (forecast USD -0.0275)
03:00
Sep25
UnitedHealth Insurance Reaches National Coverage Agreement with Plus Therapeutics for CNSide CSF Test
12:22
Aug15
Plus Therapeutics Meets NASDAQ Listing Rules and Receives Compliance Extension
13:49
Plus Therapeutics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 2.449 M, actual EPS USD -0.5015
03:00
Plus Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.39 M (forecast USD 1.486 M), actual EPS USD -0.01 (forecast USD -0.09)
03:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.397 M, Net Income -4.423 M, EPS -0.0411

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.39 M, Net Income 1.191 M, EPS -0.0065

May30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.059 M, Net Income -13.44 M, EPS -29.5154

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATPC
0.1556
+128.82%
+0.087
PETS
3.195
+80.51%
+1.450
GEMG
10.370
+62.96%
+4.007
AXIL
8.080
+60.95%
+3.060
BEAT
2.395
+54.52%
+0.841
VELO
13.110
+52.44%
+4.474
SMX
221.165
+51.17%
+74.865
DXLG
1.570
+45.36%
+0.490
DHIL
169.710
+44.46%
+52.230
PL
17.594
+35.97%
+4.615
View More